MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares

Bulletin Express

02/16

MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.

The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.

This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1144426596"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144426596\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144426596?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-16 13:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144426596","market":"us","top_or_hot":-1,"title":"MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares","media":"Bulletin Express","content":"<p>MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.</p>\n<p>The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.</p>\n<p>This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-02-16 13:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.</p>\n<p>The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.</p>\n<p>This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02235","symbol_name":"微泰醫療-B","start_time":0,"source_url":"","article_id":"1144426596","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144426596","pubTimestamp":1771220599,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02235":"微泰医疗-B"},"translate_title":"微科医疗(02235)公布H股回购及经调整库存股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02235":1},"content_text":"MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.\nThe company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.\nThis repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}